BG102758A - Method for improving of contrast means - Google Patents

Method for improving of contrast means

Info

Publication number
BG102758A
BG102758A BG102758A BG10275898A BG102758A BG 102758 A BG102758 A BG 102758A BG 102758 A BG102758 A BG 102758A BG 10275898 A BG10275898 A BG 10275898A BG 102758 A BG102758 A BG 102758A
Authority
BG
Bulgaria
Prior art keywords
contrast means
microscopic
relates
improving
contrast
Prior art date
Application number
BG102758A
Other languages
Bulgarian (bg)
English (en)
Inventor
Harald Dugstad
Jo Klaveness
Pal Rongved
Roald Skurtveit
Jorun Braenden
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603466.5A external-priority patent/GB9603466D0/en
Priority claimed from GBGB9611894.8A external-priority patent/GB9611894D0/en
Priority claimed from GBGB9625663.1A external-priority patent/GB9625663D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of BG102758A publication Critical patent/BG102758A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BG102758A 1996-02-19 1998-09-09 Method for improving of contrast means BG102758A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9603466.5A GB9603466D0 (en) 1996-02-19 1996-02-19 Improvements in or relating to contrast agents
GBGB9611894.8A GB9611894D0 (en) 1996-06-07 1996-06-07 Improvements in or relating to contrast agents
GBGB9625663.1A GB9625663D0 (en) 1996-12-11 1996-12-11 Improvements in or relating to contrast agents
PCT/GB1997/000459 WO1997029783A1 (en) 1996-02-19 1997-02-19 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
BG102758A true BG102758A (en) 1999-09-30

Family

ID=27268137

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102758A BG102758A (en) 1996-02-19 1998-09-09 Method for improving of contrast means

Country Status (24)

Country Link
US (4) US6221337B1 (cg-RX-API-DMAC10.html)
EP (2) EP0881915B1 (cg-RX-API-DMAC10.html)
JP (1) JP4418033B2 (cg-RX-API-DMAC10.html)
KR (1) KR100500334B1 (cg-RX-API-DMAC10.html)
CN (1) CN1278740C (cg-RX-API-DMAC10.html)
AP (1) AP890A (cg-RX-API-DMAC10.html)
AT (1) ATE238072T1 (cg-RX-API-DMAC10.html)
AU (1) AU726503B2 (cg-RX-API-DMAC10.html)
BG (1) BG102758A (cg-RX-API-DMAC10.html)
CA (1) CA2246779C (cg-RX-API-DMAC10.html)
CZ (1) CZ293986B6 (cg-RX-API-DMAC10.html)
DE (1) DE69721235T2 (cg-RX-API-DMAC10.html)
EA (1) EA001135B1 (cg-RX-API-DMAC10.html)
EE (1) EE04224B1 (cg-RX-API-DMAC10.html)
ES (1) ES2197986T3 (cg-RX-API-DMAC10.html)
HU (1) HU229090B1 (cg-RX-API-DMAC10.html)
IL (1) IL125748A (cg-RX-API-DMAC10.html)
NZ (1) NZ331509A (cg-RX-API-DMAC10.html)
OA (1) OA10839A (cg-RX-API-DMAC10.html)
PL (1) PL328406A1 (cg-RX-API-DMAC10.html)
PT (1) PT881915E (cg-RX-API-DMAC10.html)
SK (1) SK284200B6 (cg-RX-API-DMAC10.html)
TR (1) TR199801613T2 (cg-RX-API-DMAC10.html)
WO (1) WO1997029783A1 (cg-RX-API-DMAC10.html)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918546B1 (en) * 1996-08-02 2008-10-15 GE Healthcare AS Improvements in or relating to contrast agents
AU784367B2 (en) * 1996-08-02 2006-03-16 Ge Healthcare As Improvements in or relating to contrast agents
JP4317270B2 (ja) * 1997-08-12 2009-08-19 ブラッコ・リサーチ・ソシエテ・アノニム 投与性組成物および磁気共鳴画像法
GB9717476D0 (en) * 1997-08-18 1997-10-22 Nycomed Imaging As Process
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717588D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717542D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9726773D0 (en) 1997-12-18 1998-02-18 Nycomed Imaging As Improvements in or relating to ultrasonagraphy
AU3719799A (en) * 1998-04-28 1999-11-16 Nycomed Imaging As Improvements in or relating to separation processes
GB9813568D0 (en) 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6514209B1 (en) 1999-06-07 2003-02-04 Drexel University Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals
US20030103960A1 (en) * 1999-12-22 2003-06-05 Pierre Philippart Sealant and bone generating product
EP2286843A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
KR100373712B1 (ko) * 2000-12-23 2003-02-25 사회복지법인삼성생명공익재단(삼성서울병원) 초음파 조영제 및 그의 제조방법
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
EP1387637B1 (en) 2001-04-06 2007-10-31 Bracco Research S.A. Apparatus for measuring local physical parameters in a fluid filled cavity
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
SI2301587T1 (sl) 2002-03-01 2014-11-28 Dyax Corp. KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
KR20050072496A (ko) 2002-11-29 2005-07-11 아머샴 헬스 에이에스 초음파 촬영 방법
WO2004069284A2 (en) * 2003-02-04 2004-08-19 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
AU2004217894B2 (en) 2003-03-03 2010-07-15 Bracco International B.V. Peptides that specifically bind HGF receptor (cMet) and uses thereof
WO2005002546A1 (en) * 2003-06-27 2005-01-13 Smithkline Beecham Corporation Stabilized topotecan liposomal composition and methods
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
NO20035401D0 (no) * 2003-12-04 2003-12-04 Amersham Health As Metode
CN1897978B (zh) * 2003-12-22 2011-11-23 博莱科瑞士股份有限公司 具有用于反差成像的活性组分的充气微囊组件
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
EP1784228B1 (en) 2004-08-18 2016-10-05 Bracco Suisse SA Gas-filled microvesicles composition for contrast imaging
WO2006044996A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for automated boundary detection of body structures
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
US10687785B2 (en) 2005-05-12 2020-06-23 The Trustees Of Columbia Univeristy In The City Of New York System and method for electromechanical activation of arrhythmias
EP1937151A4 (en) * 2005-09-19 2011-07-06 Univ Columbia Systems and methods for opening of the blood-brain barrier of a subject using ultrasound
CA2631716C (en) 2005-12-09 2013-11-26 Bracco International B.V. Targeting vector-phospholipid conjugates
EP1797919A1 (en) 2005-12-16 2007-06-20 Bracco Research S.A. Liquid transfer device for medical dispensing containers
AR059193A1 (es) 2006-01-31 2008-03-12 Bayer Schering Pharma Ag Modulacion de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
EP2076179B1 (en) 2006-08-01 2018-07-04 Stichting voor de Technische Wetenschappen Pulse inversion sequences for nonlinear imaging
WO2008027520A2 (en) * 2006-08-30 2008-03-06 The Trustees Of Columbia University In The City Of New York Systems and methods for composite elastography and wave imaging
DE602007006968D1 (de) 2006-09-05 2010-07-15 Bracco Research Sa Gasgefüllte mikrovesikel mit polymer-modifizierten lipiden
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
WO2011035312A1 (en) 2009-09-21 2011-03-24 The Trustees Of Culumbia University In The City Of New York Systems and methods for opening of a tissue barrier
JP2010005512A (ja) * 2008-06-25 2010-01-14 Kao Corp 微細気泡前駆体組成物
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2010014977A1 (en) * 2008-08-01 2010-02-04 The Trustees Of Columbia University In The City Of New York Systems and methods for matching and imaging tissue characteristics
WO2010030819A1 (en) 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Systems and methods for opening a tissue
WO2010030779A1 (en) * 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Isolation of microbubbles of selected size range from polydisperse microbubbles
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
EP2477550A4 (en) * 2009-09-15 2013-12-04 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR MICROBUBBLES
US9700640B2 (en) * 2009-09-21 2017-07-11 Drexel University Stabilized ultrasound contrast agent
US8834846B2 (en) 2010-05-06 2014-09-16 Bruker Biospin Corporation Fluorescent NIRF activatable probes for disease detection
US9265483B2 (en) 2010-08-06 2016-02-23 The Trustees Of Columbia University In The City Of New York Medical imaging contrast devices, methods, and systems
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2012162664A1 (en) 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
EP2844362B1 (en) 2012-04-30 2020-02-26 Ge Healthcare As Method for filling a container with a foamable composition
KR102139393B1 (ko) 2012-06-26 2020-07-29 지이 헬스케어 에이에스 기체 미세기포를 포함하는 조성물의 제조
WO2014059170A1 (en) 2012-10-10 2014-04-17 The Trustees Of Columbia University In The City Of New York Systems and methods for mechanical mapping of cardiac rhythm
US10010630B2 (en) 2012-12-21 2018-07-03 Bracco Suisse S.A. Gas-filled microvesicles
WO2014142926A1 (en) 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
EP2983687B1 (en) 2013-03-15 2019-09-04 The Regents of The University of California Peptides having reduced toxicity that stimulate cholesterol efflux
US9247921B2 (en) 2013-06-07 2016-02-02 The Trustees Of Columbia University In The City Of New York Systems and methods of high frame rate streaming for treatment monitoring
US10322178B2 (en) 2013-08-09 2019-06-18 The Trustees Of Columbia University In The City Of New York Systems and methods for targeted drug delivery
US10028723B2 (en) 2013-09-03 2018-07-24 The Trustees Of Columbia University In The City Of New York Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
GB201405735D0 (en) * 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
ES2726924T3 (es) 2014-12-18 2019-10-10 Bracco Suisse Sa Formulación de microvesículas dirigidas rellenas de gas
EP3308779B1 (en) * 2015-06-10 2019-08-07 Teikyo University Theranostic bubble preparation (tb), and method for using same
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (cg-RX-API-DMAC10.html) * 1990-04-02 1993-05-01 Sint Sa
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9511488D0 (en) * 1995-06-07 1995-08-02 Nycomed Imaging As Improvements in or relating to contrast agents
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator

Also Published As

Publication number Publication date
EP0881915B1 (en) 2003-04-23
PT881915E (pt) 2003-09-30
AP9801319A0 (en) 1998-09-30
US6221337B1 (en) 2001-04-24
JP4418033B2 (ja) 2010-02-17
US20030202942A1 (en) 2003-10-30
ES2197986T3 (es) 2004-01-16
EP1331013A3 (en) 2004-03-24
HUP9900813A3 (en) 1999-11-29
TR199801613T2 (xx) 1998-11-23
EP0881915A1 (en) 1998-12-09
OA10839A (en) 2001-08-13
DE69721235D1 (de) 2003-05-28
PL328406A1 (en) 1999-01-18
EE04224B1 (et) 2004-02-16
IL125748A (en) 2002-05-23
EA001135B1 (ru) 2000-10-30
EP1331013A2 (en) 2003-07-30
SK112698A3 (en) 1999-04-13
AU1884797A (en) 1997-09-02
WO1997029783A1 (en) 1997-08-21
ATE238072T1 (de) 2003-05-15
CA2246779C (en) 2008-04-29
US20010010811A1 (en) 2001-08-02
IL125748A0 (en) 1999-04-11
NZ331509A (en) 2000-04-28
CZ262598A3 (cs) 1999-05-12
DE69721235T2 (de) 2004-02-05
HK1014872A1 (en) 1999-10-08
EA199800745A1 (ru) 1999-02-25
AU726503B2 (en) 2000-11-09
SK284200B6 (sk) 2004-10-05
KR100500334B1 (ko) 2005-09-09
CN1278740C (zh) 2006-10-11
HUP9900813A2 (hu) 1999-07-28
JP2000511510A (ja) 2000-09-05
US20050201942A1 (en) 2005-09-15
CZ293986B6 (cs) 2004-09-15
AP890A (en) 2000-11-13
EE9800249A (et) 1999-02-15
HU229090B1 (en) 2013-07-29
KR19990082669A (ko) 1999-11-25
CN1213972A (zh) 1999-04-14
CA2246779A1 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
BG102758A (en) Method for improving of contrast means
CA2025298A1 (fr) Nouveau procede de preparation de microparticules lipidiques
GR3030206T3 (en) Cationic lipids.
EP1308553A3 (en) Functional fiber products and process for producing same
WO2003086280A3 (en) Immunostimulatory g,u-containing oligoribonucleotides
DE69725877D1 (de) Kationische lipid-nukleinsäure komplexe
AU4151099A (en) Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
ZA200203102B (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same.
ATE301709T1 (de) Lipidabkömmlinge von pentaerythritol
HUT43080A (en) Compositions containing phospholipide and process for producing them
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
CA2030951A1 (en) Process for producing immunostimulant agents
CA2366705A1 (en) Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields
EP1137650A4 (en) PROCESS FOR OBTAINING DEHILED PHOSPHATIDES
GB2322132B (en) Keratinocyte growth factor-2 products
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
ATE214708T1 (de) Kationische mittel zur transfektion von nukleinsäuren
CA2205790A1 (en) Process for preparing amino-silane compounds, and novel amino-silane compounds
EP0096932A3 (en) Process for making a lyophilized product for use in skeletal imaging
AU9080398A (en) Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them
FR2620333B1 (fr) Liposomes, leur procede de preparation et application desdits liposomes comme vecteur de produits
PT94480A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de isoxazolin-3-ona uteis como antidepressivos
HUT76859A (en) 4-halo-2-fluoro-5-alkoxybenzoyl derivatives, process for preparing such compounds and intermediates thereof
MY115259A (en) Process for the preparation of nmda antagonists